Myrcludex B, the idea of which belonged to the 2nd largest European
research institutes (National Institute of Health and Medical
Research INSERM, France, and the University of Heidelberg, Germany), a peptide and to block the penetration of hepatitis B and D into normal hepatocytes (liver cells) , thus creating a reserve for liver tissue repair and prevent progression of the disease and the development of complications such as cirrhosis and hepatocellular carcinoma.